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Interactions between the host and viruses during the course of their co-evolution
have not only shaped cellular function and the immune system, but also the counter
measures employed by viruses. Relatively small genomes and high replication rates
allow viruses to accumulate mutations and continuously present the host with new
challenges. It is therefore, no surprise that they either escape detection or modulate
host physiology, often by redirecting normal cellular pathways to their own advantage.
Viruses utilize a diverse array of strategies and molecular targets to subvert host
cellular processes, while evading detection. These include cell-cycle regulation, major
histocompatibility complex-restricted antigen presentation, intracellular protein transport,
apoptosis, cytokine-mediated signaling, and humoral immune responses. Moreover,
viruses routinely manipulate the host cell cycle to create a favorable environment for
replication, largely by deregulating cell cycle checkpoints. This review focuses on our
current understanding of the molecular aspects of cell cycle regulation that are often
targeted by viruses. Further study of their interactions should provide fundamental
insights into cell cycle regulation and improve our ability to exploit these viruses.
Keywords: viruses, cell cycle, checkpoint, infection, life cycle, host-pathogen interactions, phosphorylation,
degradation
INTRODUCTION
The study of host-pathogen interaction and the search for host factors that are crucial for
virus life cycle is critical to the understanding of viral pathogenesis, and may shed light on the
development of therapeutic approaches. Viruses are obligate intracellular parasites that constantly
evolve strategies to subvert their host cellular environment. As survival of viruses depend on the
ability to replicate in living organisms, it is not surprising that they are able to arrest or promote cell
cycle progression, depending on the purpose, to their advantage. Viruses that are associated with
malignancies, such as human T-cell leukemia virus type I (HTLV-1), Epstein-Barr virus (EBV),
human papilloma virus (HPV), and Kaposi’s sarcoma-associated herpesvirus (KSHV), have long
been known to antagonize cell cycle checkpoints for neoplastic transformation of infected cells
(Dyson et al., 1989; Moore and Chang, 1998; Knight and Robertson, 2004; Iwanaga et al., 2008).
Thus, Simian virus 40 (SV40) and HPV promote entry of host cell cycle into the S phase as viral
DNA replication depends on the host DNA replication machinery (Lehman et al., 2000; Banerjee
et al., 2011). In contrast, human immunodeficiency virus type 1 (HIV-1) infection of T lymphocytes
results in a cell cycle arrest in G2, suggesting that HIV-1 may disrupt T-cell-mediated immune
response by preventing its clonal expansion (Zimmerman et al., 2006). The avian coronavirus
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infectious bronchitis virus (IBV) also promotes favorable
conditions for viral protein synthesis and, hence, progeny virus
production, by inducing cell cycle G2/M phase arrest of virus-
infected cells (Dove et al., 2006).
The investigation ofmechanisms viruses employ to hijack host
cell cycle is, therefore, of significance not only for insights into the
intracellular viral lifecycle, but also for development of strategies
to counteract viral infection. Viruses associated with human
cancer have been the focus of scores of studies that have led to
the identification of cellular networks regulating the cell cycle,
including the discovery of oncogenes and tumor suppressor
genes (Bishop, 1991; Weinberg, 1991). While discussion of their
manipulation of the cell cycle is inevitable, oncogenic viruses
will not be the focus of this article and the reader is referred to
a number of excellent reviews on this topic (Weinberg, 1997;
zur Hausen, 2001; Chang et al., 2017). Rather, we summarize
and discuss here current concepts of the mechanistic features
that non-oncogenic viruses adopt to modify host cell cycle
machinery.
OVERVIEW OF THE CELL CYCLE
Cell cycle, or cell-division cycle, is a highly regulated process
during which a cell undergoes duplication and division leading
to the generation of two daughter cells. The eukaryotic cell cycle
is generally divided into four stages: gap 1 phase (G1), synthesis
phase (S), gap 2 phase (G2), and mitotic phase (M). In between
M and G1, a cell may enter a quiescent state called gap 0 phase
(G0), during which cells are neither dividing nor preparing to
divide.
G1 is the phase during which metabolic changes take
place to prepare the cell for division. Events that take place
in G1 include growth in cell size as well as mRNA and
protein synthesis. Initiation of G1 phase requires growth factor
stimulation and a continuous supply of growth factor until
the cell cycle passes through the restriction point (Pardee,
1974) in G1, after which cells are committed to DNA synthesis
to complete the cell cycle and become extracellular growth
factor-independent throughout the remainder of the cell cycle
(Zetterberg et al., 1995). The retinoblastoma (Rb) protein is
the guardian of restriction point (Bartek et al., 1996). When
conditions are propitious for cell division without warning
signals such as DNA damage or metabolic disturbances, Rb
undergoes phosphorylation and become functionally inactivated,
permitting the cell to proceed into late G1 (Weinberg, 1995).
DNA synthesis takes place in S phase, generating exactly two
identical sister chromosomes. G2 phase is a period of rapid cell
growth and protein synthesis during which cells get ready for
mitosis. DNA damage and replication checkpoint exists in G2
to monitor if chromosome replication is successfully completed
and whether DNA damage occurs during the process (Hartwell
and Weinert, 1989). This checkpoint determines the fate of a
cell, either to enter mitosis or to undergo growth arrest for
DNA repair. Mitosis is the process during which eukaryotic
sister chromatid get separated to generate two nuclei (Pines
and Rieder, 2001). A metaphase checkpoint detects whether all
chromosomes are properly attached to mitotic spindles (spindle
checkpoint), to ensure equal separation of sister chromatid
(Gorbsky, 1995). Cell division is completed by cytokinesis, which
segregates the nuclei, cytoplasm, organelles, and cell membrane
into two genetically identical daughter cells (Straight and Field,
2000; Glotzer, 2001). Thus, cell cycle is a highly regulated process
where multiple checkpoints determine whether to continue or
abort a division.
The initiation of specific events during cell cycle, such
as preparation for cell division, DNA replication, nuclear
membrane breakdown, spindle formation and chromosome
segregation, is triggered by a series of protein complexes that
are activated in a concerted fashion. The protein complexes,
consisting of cyclin and cyclin dependent kinase (CDK),
constitute the cell cycle engine, which is driven in a precise
sequence with different cyclin-CDK partners activated at specific
points of the cell cycle. Mammalian cells accommodate multiple
cell cycle-regulatory cyclin and CDKs throughout the cell cycle
machinery probably to fine-tune the flexibility of cell cycle
control (Nigg, 1995).
After mammalian cells are released from the quiescent state,
the first cyclin-CDK holoenzyme known to be activated is
composed of a D-type cyclin and either CDK4 or CDK6
depending on the cell type (Matsushime et al., 1994). Cyclin D
functions as growth factor sensor, the expression of which is
stimulated by growth factor and is independent of the state of
the cell cycle (Sherr, 1993). Knowledge of the role of D-type
cyclin in G1 progression was obtained from the observation
that microinjection of anti-cyclin D1 antibodies into fibroblasts
that were in G1 phase prevent them from entering into S
phase (Baldin et al., 1993). On the contrary, overexpression
of cyclin D1 shortens the duration of G1 phase in mouse
fibroblasts, demonstrating cyclin D1 is a rate limiting factor
for G1 progression (Quelle et al., 1993). Assembly of cyclin D-
CDK4/6 complexes facilitates the phosphorylation of CDK4/6
by a CDK-activating kinase (CAK), which is required for the
phosphorylation and enzymatic activation of CDKs (Kato et al.,
1994; Kaldis et al., 1998). CAK is composed of three subunits,
CDK7, cyclin H and MAT1 (ménage à trois) (Devault et al.,
1995). Specifically, phosphorylation of CDKs at Thr161/160/172
by CAK is essential for stabilization of CDK/cyclin complexes by
inducing a conformational change that increases the flexibility of
the T-loops of all CDKs tested and enables access of the cyclin
substrate (Matsuoka et al., 1994; Brown et al., 1999; Morris et al.,
2002).
Activated cyclin D-CDK4/6 complexes phosphorylate Rb,
which gets further phosphorylated by cyclin E-CDK2 complex
at the mid-to-late G1 phase. Hyperphosphorylation inactivates
Rb and leads to the release of transcription factor E2F, which
activates the transcription of other cell cycle promoting genes,
from the blocking effect imposed by hypophosphorylated Rb
(Ewen et al., 1993; Weinberg, 1995). From this time on, cell cycle
becomes independent of growth factor stimulation for continued
cell cycle progression.
Further progression into S phase is driven by cyclin E-CDK2,
and thereafter cyclin A-CDK2 promotes the completion of S
phase. The precise role cyclin-CDK complexes play in the control
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 November 2018 | Volume 8 | Article 396
Fan et al. Host-Pathogen Interactions in the Cell Cycle
of DNA replication is poorly defined. It appears that cyclin E-
CDK2 is involved in centrosome duplication (Lacey et al., 1999),
and CDK2 is necessary for DNA replication in a cell-free system
(Krude et al., 1997). Following DNA synthesis, cells enter into
G2 phase and CDK1 is believed to catalyze events in G2/M phase
through sequential association with cyclin A and cyclin B. It is
reported that the complexing of both cyclin A-CDK2 in late S
phase and cyclin A-CDK1 in G2/M phase inactivate anaphase
promoting complex/cyclosome (APC/C) to ensure accumulation
of key mitotic regulators (Mitra et al., 2006).
Maturation/M phase-promoting factor (MPF) refers to the
universal inducer of entry into M phase in eukaryotic cell. Cyclin
B-CDK1 is one major component of the MPF complex (Hunt,
1989; Nurse, 1990). Purified cyclin B-CDK1 can induce meiotic
G2/M transition upon injection into immature oocytes (Lohka
et al., 1988). Proteins that regulate chromosomal condensation,
formation of mitotic spindles, and fragmentation of the Golgi
apparatus become the substrates of CDK1 during M phase,
underscoring the importance of cyclin B-CDK1 complex (Lowe
et al., 1998).
Study with CDK or cyclin knockout mice challenged the
traditional orderly scheme of cell cycle progression described
above. Mice survive in the absence of individual interface CDKs
(Rane et al., 1999; Tsutsui et al., 1999; Ye et al., 2001; Berthet
et al., 2003; Malumbres et al., 2004), and similar results have been
obtained on ablation of cyclin D and cyclin E (Geng et al., 2003;
Kozar et al., 2004). It has been shown that CDK4 and CDK6
partner only D-type cyclins, whereas both CDK1 andCDK2 show
promiscuity in their choice of cyclin partners and exhibit binding
ability with cyclin A, B, D, and E (Aleem et al., 2005; Petri et al.,
2007; Santamaría et al., 2007). Thus, a minimal threshold model
of cell cycle control has emerged, which suggests that pairing of
cyclin A to either CDK1 or CDK2 is sufficient to trigger G1/S
transition, whereas cyclin B-CDK1 activity seems to be required
for mitosis.
CELL CYCLE SUBVERSION IN VIRAL
INFECTION
Viruses keep evolving strategies to subvert the cellular
environment of the host for replication and survival. For
example, some viral infections induce cell cycle arrest in
lymphocytes to inhibit the clonal expansion of anti-viral T or B
lymphocytes as a way of immune evasion, whereas carcinogenic
viruses are known to antagonize cell cycle checkpoints for
neoplastic transformation of infected cells. Thus, elucidating
mechanisms of virus-induced deregulation of host cell cycle
bears both fundamental and translational relevance.
SUBVERSION BY PROTEIN-PROTEIN
INTERACTION (TABLE 1, FIGURE 1)
Normal cellular function including signal transduction and
metabolic processes is often mediated through protein-protein
interactions, and are routinely targeted by viruses. The host cell
cycle is no exception, as illustrated below.
Cyclin or CDK
Cyclin and CDK are components that drive the cell cycle clock
by forming an active protein complex that could be directly
targeted by viruses to modulate cell cycle progression. Binding
of the oncoprotein Tax of HTLV-1 to cyclin D1/D3 was observed
in transfected cells by co-immunoprecipitation (Neuveut et al.,
1998). This interaction is implicated in the ability of Tax to
promote progression through S phase, as cells expressing a
cyclin D3deficient in Tax-binding exhibit much lesser thymidine
incorporation (Neuveut et al., 1998). Interestingly, Haller et al.
later demonstrated that Tax could also stimulate CDK4 activity
through direct physical interaction via its N-terminal region
(Haller et al., 2002). A binding-deficient Tax variant failed to
stimulate CDK4-cyclin D complex formation and lost its ability
to antagonize the inhibitory effect of cyclin-dependent kinase
inhibitor (CKI) p21WAF1/CIP1, underlying the importance of
protein interaction in Tax-mediated cell cycle regulation (Haller
et al., 2002). Chronic hepatitis B virus (HBV) infection is
associated with the development of hepatocellular carcinoma,
and the X protein of HBV (HBx) was found to stimulate S phase
entry of growth-arrested cells (Benn and Schneider, 1995). Co-
immunoprecipitation in HBx-expressing cells demonstrated that
this viral protein binds to cyclin E/A-CDK2 complexes. Mutant
HBx, which displayed disrupted interaction with cyclin-CDK
complexes, failed to increase CDK2 activity and, similarly to
Tax, lost its effectiveness in counteracting the action ofp27KIP1
(Mukherji et al., 2007).
The examples of Tax and Hobs illustrate how binding of viral
protein to cyclin or CDK promotes cell cycle progression either
by enhancing kinase activity and/or weakening the inhibitory
effect of CKI. The interaction of viral protein with cyclin or CDK
could also results in hampered cell division. A direct binding of
the K-bZIP protein of KSHV to CDK2, cyclin A, or cyclin E has
been demonstrated using purified proteins (Izumiya et al., 2003).
These interactions were found to impair the kinase activity of
CDK2, leading to extended G1 duration, which is accompanied
by increased production of the negative regulators p21WAF1/CIP1
and p27KIP1 (Izumiya et al., 2003). Interestingly p30, another
HTLV-1 expressing protein, blocks G1/S transition in contrast to
the neoplastic effect of Tax. CyclinE-CDK2 complex formation is
hindered in p30 expressing cells due to the interaction of p30 with
both cyclin E and CDK2, leading to reduced phosphorylation
of the Rb tumor suppressor protein (Baydoun et al., 2010).
Infection of influenza A virus (IAV) has been reported to induce
host cell cycle G0/G1 phase accumulation (He et al., 2010; Fan
et al., 2017). A yeast two-hybrid screen using the cytoplasmic
tail of matrix protein 2 (M2) from the highly pathogenic H5N1
strain revealed a high-score interaction with cyclin D3. The M2
ion channel protein is a multifunctional protein with a highly
conserved sequence among IAV isolates that approaches 95%
identity in some regions (Le and Leluk, 2011; Pielak and Chou,
2011). The physical interaction between M2 and cyclin D3 was
confirmed in virus-infected cells, was accompanied by cyclin D3
relocalization and degradation, and resulted in host cell cycle
arrest in the G0/G1 phase (Fan et al., 2017). The interaction of
viral protein with host cell cyclemachinery is not always favorable
for viral life cycle. Using a combination of small interfering
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TABLE 1 | Cell cycle subversion by protein-protein interaction.
Virus/Genome Viral protein Host protein Functional consequence References
HTLV-1/RNA plus Tax Cyclin D1/D3 Progression through S phase Neuveut et al., 1998
HTLV-1/RNA plus Tax CDK4 Antagonism to CKI p21WAF1/CIP1 Haller et al., 2002
HTLV-1/RNA plus Tax p16INK4A Antagonism to p16INK4A-imposed blockage of
G1 to S transition
Suzuki et al., 1996; Low et al., 1997
HTLV-1/RNA plus Tax p15INK4A, p15INK4B Restoration of CDK4 activity Suzuki et al., 1999
HTLV-1/RNA plus Tax Chk1, Chk2 Inhibition of kinase activity Park et al., 2004, 2006
HTLV-1/RNA plus Tax DNA-PK Impairment of the cellular DNA damage
response
Durkin et al., 2008
HTLV-1/RNA plus p30 cyclin E, CDK2 Block of G1/S transition Baydoun et al., 2010
HIV-1/RNA plus Tat p53 Loss of G1/S checkpoint Clark et al., 2000
HIV-1/RNA plus Vpr Wee1, Cdc25C, SLX4,
DDB1
G2/M arrest McGowan and Russell, 1993; Goh
et al., 2004; Schröfelbauer et al.,
2007; Kamata et al., 2008; Laguette
et al., 2014
HBV/circular DNA HBx cyclin E/A-CDK2 Stimulation of entry into S phase Izumiya et al., 2003
HBV/circular DNA HBx DDB1 Delayed S phase progression Leupin et al., 2003; Martin-Lluesma
et al., 2008
KSHV/dsDNA K-bZIP CDK2, cyclin A, cyclin E Impairment of CDK2,leading to extended G1
duration
Izumiya et al., 2003
HCV/RNA plus Core protein p21WAF1/CIP1 Disruption of PCNA-p21WAF1/CIP1 binding,
impaired cell cycle arrest in G2
Wang et al., 2000
HCV/RNA plus NS3 p53 Inhibition of oligomerization and transcriptional
activation
Deng et al., 2006
HPV/dsDNA E6 p53 Inhibition of transactivation Werness et al., 1990; Mietz et al.,
1992
HPV/dsDNA E7 p27KIP1 Inhibition of CKI Zerfass-Thome et al., 1996; Funk
et al., 1997; Jones et al., 1997
HPV/dsDNA E7 Rb Dissociation of E2F-Rb/p107 complexes Barbosa et al., 1990; Huang et al.,
1993; Wu et al., 1993
Avian Reovirus/dsRNA p17 CDK1, CDK2, CDK4,
CDK6, Cyclin A1, Cyclin D1,
Cyclin E1
Cell growth retardation, enhanced replication Chiu et al., 2018
Influenza A/RNA minus M2 Cyclin D3 Cell cycle arrest in G0/G1 He et al., 2010; Fan et al., 2017
Influenza A/RNA minus NS1 RhoA G-/G1 cell cycle arrest Jiang et al., 2013
Adenovirus/dsDNA E1A p27KIP1 Impairment of p27KIP1 inhibition on CDK2 Mal et al., 1996
Adenovirus/dsDNA E1A Rb Dissociation of E2F-Rb/p107 complexes Bagchi et al., 1990; Raychaudhuri
et al., 1991; Ikeda and Nevins, 1993
Adenovirus/dsDNA E1A p300, CBP Inhibition of the activation of p21WAF1/CIP1,
blocking p53-dependent cell cycle arrest
Somasundaram and El-Deiry, 1997
HCMV/dsDNA IE2-86 CKI Impaired cell cycle arrest in G2 Sinclair et al., 2000
HCMV/dsDNA IE2-86, mtrII p53 Repression of p53 function Speir et al., 1994; Thompson et al.,
1994; Muralidhar et al., 1996; Tsai
et al., 1996
SV40/dsDNA Large T
antigen
Rb Dissociation of E2F-Rb/p107 complexes Zalvide et al., 1998; Sullivan et al.,
2000
SV40/dsDNA Large T
antigen
p53 Inhibition of transactivation Mietz et al., 1992
Epstein-Barr/dsDNA EBNA-5,
BRLF1
Rb G0 to G1 progression Szekely et al., 1993; Zacny et al.,
1998
Epstein-Barr/dsDNA EBNA-3C Chk2 Reduced Cdc25C phosphorylation, abrogation
of the G2/M checkpoint
Choudhuri et al., 2007
RNA (siRNA) mediated genetic analysis it has become clear
that cyclin D3 restricts IAV production independent of its role
in cell cycle. The biogenesis of viral particles involves proper
packaging and assembly of viral proteins and RNA to form
intact virions at discrete budding sites. M2 is a multifunctional
protein: its cytosolic tail interacts with M1, promoting the
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recruitment of viral internal proteins and viral RNA to the plasma
membrane for efficient virus assembly (Chen et al., 2008). The
inhibitory effect of cyclin D3 on IAV infection is due to its
interaction with viral M2 protein, as measured by competitive
co-immunoprecipitation assays, indicating that cyclin D3-M2
interaction either masks the domain on M2 mediating binding
to M1, or has a higher affinity than that between M1 and
M2. Consequently, limited M1-M2 binding during the budding
process of IAV infection results in less progeny virions being
efficiently packaged and released from host cells (Fan et al.,
2017). These observations suggest a novel function of cyclin
D3 that is beyond its classical function in cell cycle regulation.
Hence, in this armed-race between cyclin D3 and M2 during
IAV infection, the virus evolved strategies to counteract the
inhibition imposed by cyclinD3, resulting in hampered cell cycle
progression. Most recently, Chiu et al. identified a negatively
charged pocket, formed by several conserved acidic residues,
which is required for the binding of p17 protein of avian reovirus
(ARV) to CDK1 (Chiu et al., 2018). Through GST-pull down
assay and in vitro kinase assay, the authors showed that p17
competes with cyclin B1 for CDK1 binding and this direct
interaction of p17 with CDK1 inhibits the kinase activity of the
latter, thus preventing cells from entering mitosis and enhancing
virus replication (Chiu et al., 2016, 2018). Unlike its exquisite
binding to CDK1 but not cyclin B1, p17 could also suppress
CDK2 and CKD4 kinase activities by direct binding to CDKs,
partner cyclins, and CDK/cyclin complexes (Chiu et al., 2018).
CKI
Cyclin-dependent kinase inhibitors are a family of proteins that,
acting through separate pathways, determine in cooperation with
cyclins and CDKs the decision of the cell to progress through the
cell cycle. The adenovirus early region 1A (E1A) protein displays
the ability to bind multiple host factors for the manipulation
of cell cycle progression. Binding of E1A to p27KIP1 blocks
its inhibitiononCDK2 kinase activity, overcoming transforming
growth factor (TGF)-β-induced cell cycle arrest in late G1 phase
(Mal et al., 1996). This provided the first evidence that a viral
oncoprotein could manipulate the cell cycle by counteracting an
inhibitor of CDKs. In addition to its association with cyclins,
HTLV-1 Tax is also able to interact with p16INK4A and relieve
p16INK4A-imposed blockage of G1 to S transition, demonstrated
by the finding that binding-deficient Tax could not protect CDK4
from the inhibitory effect of p16INK4A (Suzuki et al., 1996; Low
et al., 1997). Suzuki et al. found that the co-precipitation of
p16INK4A by CDK4was drastically reduced in the presence of Tax,
providing direct proof that Tax activates CDK4 by disabling the
formation of p16INK4A-CDK4 complex (Suzuki et al., 1996). In a
similar manner, Tax restores CDK4 activity through interaction
with p15INK4B, further contributing to the immortalization of
T cells (Suzuki et al., 1999). Interestingly, while Tax directly
antagonizes p16INK4A and p15INK4B through protein-protein
interaction, it utilizes a different mechanism to repress p18INK4C
transcription and further promote cell transformation (Suzuki
et al., 1999).
It was reported that p21WAF1/CIP1 could block the interaction
between cell division cycle 25C (Cdc25C), a phosphatase of
CDK1 that activates the CDK1/cyclin B1 complex (Strausfeld
et al., 1991), and proliferating cell nuclear antigen (PCNA) by
competing with Cdc25C for PCNA binding. This observation
points to a role of p21WAF1/CIP1 in G2 cell cycle arrest upon DNA
damage (Ando et al., 2001). Formation of a complex between
the core protein of hepatitis C virus (HCV), which plays an
important role in the development of hepatocellular carcinomas,
and p21WAF1/CIP1 was mapped to the C-terminus of this CKI,
a region in the close vicinity of the PCNA binding site of
p21WAF1/CIP1 (Wang et al., 2000). In vitro experiments revealed
that a competition exists between core protein and PCNA for the
association with p21WAF1/CIP1 (Wang et al., 2000). It is plausible
to speculate that, in the case of HCV infection, expression of
core protein may disrupt PCNA-p21WAF1/CIP1 binding, leading
to impaired cell cycle arrest in G2 and DNA repair in response
to damage signals. Other examples of viral protein-mediated
inhibition of CKIs include the E7 oncoprotein of HPV-16 and the
immediate-early (IE) protein IE2-86 of human cytomegalovirus
(HCMV) (Zerfass-Thome et al., 1996; Funk et al., 1997; Jones
et al., 1997; Sinclair et al., 2000).
Rb/Pocket Proteins or E2Fs
Growth factors are necessary to drive the cell cycle machinery
to the restriction point, beyond which commitment to cell
cycle progression occurs and the cell enters S phase without
requiring extracellular mitogenic signals. Retinoblastoma (Rb)
protein, which serves as the guardian of restriction point,
represents a non-redundant checkpoint that can be targeted
by viruses to modulate host cell cycle under growth limiting
conditions (Blagosklonny and Pardee, 2002). For example, the
adenovirus E1A not only associates with CKI, but also functions
to dissociate E2F-Rb/p107 complexes owing to the interaction
of its two conserved regions (CRs) with Rb (Bagchi et al., 1990;
Raychaudhuri et al., 1991). It was proposed that the LXCXE
motif-containing CR2 of E1A mediates its initial binding to Rb,
allowing CR1 to block the sequences on Rb that are involved
in E2F recognition by means of physical interaction (Ikeda and
Nevins, 1993). The release of E2F, therefore, transcriptionally
activates various downstream target genes that are required for
proliferation and DNA synthesis, including c-myc and cyclin
E (Roussel et al., 1994; Ohtani et al., 1995). Similarly, HPV
E7 possesses two homology regions of CR1 and CR2, which
contribute to the transformation properties of E7 through
disruption of E2F-Rb complexes (Barbosa et al., 1990; Huang
et al., 1993; Wu et al., 1993). The association of the SV40 large
T-antigen (L-Tag), which is expressed early during infection
and is essential for viral replication, with Rb, p107, and p130
is attributed to the viral LXCXE residues, which are required
but not sufficient in L-Tag-mediated transformation (DeCaprio
et al., 1988; Chen and Paucha, 1990; Thompson et al., 1990;
Stubdal et al., 1996). It was reported that the N-terminus of L-
Tag, which shares sequence homology with the J domain of heat
shock protein 40 (HSP40), is also required to disrupt the complex
formation between the three “pocket” proteins of the Rb family
with E2F (Zalvide et al., 1998; Sullivan et al., 2000).
The nuclear antigen 5 (EBNA-5), also known as nuclear
antigen leader protein (EBNA-LP), of Epstein-Barr virus (EBV)
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FIGURE 1 | Cell cycle subversion by protein-protein interaction. (A) Binding of Tax and HBx proteins to cyclin and/or CDK promotes cell cycle progression either by
enhancing kinase activity and/or weakening the inhibitory effect of CKI (Benn and Schneider, 1995; Neuveut et al., 1998; Haller et al., 2002). Direct binding of either
K-bZIP protein of KSHV or p30 of HTLV-1 to both CDK2 and cyclin E leads to extended G1 duration or block of G1/S transition (Izumiya et al., 2003; Baydoun et al.,
2010). Similarly, direct interaction of M2 of influenza A virus with cyclin D3 arrested cell cycle in G0/G1 phase (Fan et al., 2017). (Bi) Binding of E1A to p27KIP1 blocks
its inhibition on CDK2 kinase activity, overcoming cell cycle arrest in late G1 phase (Mal et al., 1996). In addition to its association with cyclins, HTLV-1 Tax is also able
to interact with p16INK4A and relieve p16INK4A-imposed blockage of G1 to S transition (Suzuki et al., 1996; Low et al., 1997). (Bii) p21WAF1/CIP1 can block the
interaction between Cdc25C and proliferating cell nuclear antigen (PCNA) by competing with Cdc25C for PCNA binding. This observation points to a role of
p21WAF1/CIP1 in G2 cell cycle arrest upon DNA damage (Ando et al., 2001). Competition between core protein of hepatitis C virus and PCNA for the association with
p21WAF1/CIP1 may disrupt PCNA-p21WAF1/CIP1 binding, leading to impaired cell cycle arrest in G2 and DNA repair in response to damage signals (Wang et al.,
2000). (C) E1A protein of adenovirus functions to dissociate E2F-Rb/p107 complexes owing to the interaction of its two conserved regions with Rb (Bagchi et al.,
1990; Raychaudhuri et al., 1991). The release of E2F, therefore, transcriptionally activates various downstream target genes that are required for proliferation and DNA
synthesis, including c-myc and cyclin E (Roussel et al., 1994; Ohtani et al., 1995).
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cooperates with its nuclear antigen 2 (EBNA-2) to prompt G0
to G1 progression during the immortalization of virus-infected
cells (Sinclair et al., 1994). Unlike the E1A of adenovirus, E7 of
HPV, and L-Tag of SV40, EBNA-5 localizes with and binds to
Rb without possessing a LXCXE motif. Although study revealed
that the carboxy-terminal 45 amino acids of EBNA-5 are crucial
for B cell transformation (Jiang et al., 1991; Mannick et al.,
1991; Szekely et al., 1993), the Rb binding region on EBNA-
5 was mapped to a 66-amino acid-long peptide that locates
on the N-terminal half of this viral protein, which is also the
binding site for p53 (Szekely et al., 1993). It was found that p53
competes with Rb for EBNA-5 binding as it inhibits EBNA-5-
Rb complex formation in vitro in a dose-dependent manner.
However, inhibition of p53-EBNA-5 interaction by Rb was not
observed in a reciprocal experiment (Szekely et al., 1993). The
fact that the transformation-capable region on EBNA-5 is distinct
from its Rb/p53-binding motif suggests interaction with Rb/p53
is not related to its ability to induce B cell transformation.
Indeed, Inman et al. showed that expression of EBNA-5 could
neither relieve Rb-mediated repression of E2F1 transactivation,
nor prevent p53-induced transactivation (Inman and Farrell,
1995). However, it is possible that the association of EBNA-5
to Rb affects other aspects of its function, such as its control
of c-Abl tyrosine kinase, to aid in viral infection. In addition,
Zancy et al. reported an interaction of EBV immediate-early lytic
gene product BRLF1 with Rb in virus-infected cells (Zacny et al.,
1998). Although the interactionmotif on Rb for BRLF1 binding is
outside of its pocket region and BRLF1 does not interact with E2F,
a correlation was still observed between the kinetics of BRLF1-
Rb binding and the displacement of E2F1 from Rb, suggesting
the potential of BRLF1 in initiating cell cycle progression (Zacny
et al., 1998).
Chk
Checkpoint kinase (Chk) 1 and 2 are tumor repressor proteins
that are activated upon replication defect and/or DNA damage
(Bartek and Lukas, 2003; Haoudi et al., 2003; Park et al., 2004,
2006). Being a multifunctional viral protein, Tax of HTLV-1 is
also known to interact with Chk. Thus, expression of Tax inhibits
the kinase activity of Chk1, whereas the effect of Tax on the kinase
activity of Chk2 is controversial. Park et al. showed that Cdc25A
degradation and p53 phosphorylation (Ser20), the downstream
events of Chk1 activation, were attenuated by Tax expression
in a dose-dependent manner, suggesting that Tax inactivates
Chk1 (Hirao et al., 2000; Shieh et al., 2000; Xiao et al., 2003;
Park et al., 2004). Two domains on Tax were identified to be
important for both binding to and inhibition of Chk2, drawing
a causal relationship between physical protein interaction and
the functional inactivation of Chk family of tumor repressors
(Park et al., 2006). By contrast, Haoudi et al. described an
induction of the steady-state level of Chk2, but not Chk1, by Tax
with increased Cdc25C degradation and p53 phosphorylation
(Ser15) (Haoudi et al., 2003). Despite the fact that Chk2 was
revealed to be activated by Tax, the overall response of Chk2
to DNA damage was impaired through inhibiting the release
of Chk2 from chromatin, which is normally observed upon
exposure to ionizing radiation (Li and Stern, 2005a; Gupta et al.,
2007). This discrepancy in the regulatory role of Tax on Chk2
activity may be explained by the differences in the assay systems
adopted by these studies. Alternatively, it may reflect the dual
action of Tax during different phases of the same event, as Tax
could first induce the accumulation of Cdc25C, which undergoes
degradation at a later stage (Haoudi et al., 2003). However,
regardless of whether Tax activates or inhibits the activity of
Chk2, the cellular DNA damage response mediated by Chk2 is
dampened. In addition, an association of Tax with the DNA-
dependent protein kinase (DNA-PK), an early mediator of cell
cycle arrest via the activation of Chk2, has also been reported
(Li and Stern, 2005b; Durkin et al., 2008). Durkin et al. observed
increased DNA-PK phosphorylation, an initiating event required
for the activation of the kinase activity of DNA-PK (Li and Stern,
2005b), in Tax-expressing cells (Durkin et al., 2008). Tax-induced
constitutive signaling of the DNA-PK pathway, however, impairs
cellular response to new damage (Durkin et al., 2008). Thus,
through saturating DNA-PK-mediated damage repair response,
Tax inactivates Chk2. Furthermore, the delay and impairment of
the cellular DNA damage response imposed by Tax appears to be
regulated by molecular sequestration of DNA-PK by Tax through
physical interaction (Durkin et al., 2008). The nuclear antigen 3C
(EBNA-3C) of Bevies is another viral protein that interacts with
Chk2, resulting in reduced Cdc25C phosphorylation at Ser216.
This Chk2-dependent step causes sequestration of Cdc25C in the
cytoplasm, which prevents removal of the inhibitory phosphates
from CDKs, leading to EBNA3C-mediated abrogation of the
G2/M checkpoint and transformation in lymphoblastoid cell
lines (Choudhuri et al., 2007).
p53
The tumor suppressor, p53, was first identified as a host protein
that stably interacts with the L-Tag of SV40 (Lane and Crawford,
1979; Linzer and Levine, 1979; Tan et al., 1986). The use of
chloramphenicol (CAT) assay demonstrated that L-Tag inhibits
the transactivation function of p53, which is mediated through
physical interaction as L-Tag mutants deficient in p53 binding
fail to prevent downstream activation of gene expression (Mietz
et al., 1992). Similarly, complex formation between HPV E6,
limited only to the oncogenic HPV types (Werness et al., 1990;
Mietz et al., 1992), and p53 leads to a drastic reduction (more
than 80%) in the level of p53-mediated transactivation in CAT
assay system. HCMV IE2-86 is able to repress p53 function
via physical interaction and this inhibitory effect requires two
functional domains on IE2-86 (Speir et al., 1994; Tsai et al.,
1996). Tsai et al. showed that the N-terminus of IE2-86 was
necessary for p53-binding while the C-terminal domain was
needed to inhibit p53-mediated transactivation, suggesting that
IE2-86 is recruited by protein interaction to target p53 and exert
its inhibitory effect (Tsai et al., 1996). Another HCMV protein,
which alters p53-orchestrated cellular regulatory mechanisms,
leading to tumorigenic transformation in rodent cells, is the
morphological transforming region II (mtrII) (Thompson et al.,
1994; Muralidhar et al., 1996). It was reported that the first
49 amino acids of mtrII mediate its binding to p53 and are
sufficient to repress p53-activated transcription (Muralidhar
et al., 1996).
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Binding of the nonstructural protein 3 (NS3) of HCV to
p53 has been located to the C-terminus, a region that also
contains the oligomerization domains required for the latter
to form the bioactive homo-tetramer (Levine, 1997; Ishido and
Hotta, 1998). It has been proposed that binding of NS3 to
p53 interferes with the formation of p53 tetramer, which is
most effective in transactivating its target genes, leading to
impaired p53-dependent transcriptional activation (Deng et al.,
2006). Interestingly, other than binding to p53 itself, adenovirus
E1A targets p53-mediated transcription through interacting
with the transcriptional coactivators p300 and CREB-binding
protein (CBP) of p53 (Somasundaram and El-Deiry, 1997). As
a result, E1A inhibits the activation of p21WAF1/CIP1, abolishing
p53-dependent cell cycle arrest. An interaction between the
transactivator of transcription (Tat) of HIV-1 and p53 was
correlated to the development of acquired immune deficiency
syndrome (AIDS)-related malignancies. Thus, Clark et al. found
that the presence of Tat almost completely abolished p53-
mediated activation, leading to reduced levels of p21CIP1/WAF1
and the loss of G1/S checkpoint (Clark et al., 2000). However,
it remains to be addressed whether a causal relationship exists
between Tat-p53 interaction and the repression of p53 function,
which will require the use of p53 binding-deficient Tat.
Other Factors
Interactions of viral component with other cell-cycle regulators
have been reported for several viruses. For example, Jiang et al.
have shown that expression of influenza A virus nonstructural
protein 1 (NS1) downregulates the protein level and inhibits the
function of the Ras homolog gene family member A (RhoA),
a small GTPase that, besides its primary involvement with
formation of actin stress fibers and cytoskeletal remodeling,
mediates cell cycle G1/S transition (Jiang et al., 2013). The
inhibition of RhoA activity by NS1 was reported to be achieved
through physical interaction between the two proteins.
Wee1, a protein kinase which inactivates CDK1 by
phosphorylating the latter on Tyr15, can interact with HIV-1
viral protein R (Vpr) in cell culture, resulting in enhanced kinase
activity of Wee1 (McGowan and Russell, 1993; Kamata et al.,
2008). Although this interaction is required,it is not sufficient
for the induction of cell cycle arrest as Vpr mutants, which
are unable to induce cell cycle arrest, maintain their binding
and activation to Wee1, suggesting the existence of additional
factors in Vpr-mediated activation of the G2 checkpoint (Kamata
et al., 2008). It is interesting to note that Wee1 blocks G2toM
transition by phosphorylating CDK1, whereas Cdc25 triggers
this transition and entry into mitosis by dephosphorylating the
same residues on CDK1 (Millar and Russell, 1992). In addition
to its binding with Wee1, Vpr was also shown to associate with
Cdc25C. This binding was mapped to a site that lies near but
is distinct from the catalytic domain of Cdc25C (Goh et al.,
2004). In accordance with its activation of Wee1, Vpr inhibits
the activity of Cdc25C, most likely through its ability to bind
Cdc25C (Goh et al., 2004). Thus, Vpr targets CDK1 to mediate
G2/M arrest acting on both Wee1 and Cdc25C.
Furthermore, several groups recently demonstrated a direct
interaction of Vpr withSLX4, a scaffold for the formation of
a heterodimeric structure-specific endonuclease consisted of
MUS81 and EME1 (Fekairi et al., 2009; Muñoz et al., 2009;
Svendsen et al., 2009; Kim et al., 2013; Laguette et al., 2014).
Thus, binding of Vpr to SLX4 activates the MUS81-EME1
endonuclease, leading to replication stress. The observation
that G2/M arrest-deficient Vpr mutants fail to interact with
SLX4, and that silencing of SLX4 reduces Vpr-dependent
cell cycle perturbation highlight the significance of Vpr-SLX4
association in Vpr-induced G2/M arrest (Laguette et al., 2014). In
accordance, the use of a panel of simian immunodeficiency virus
(SIV) Vprs that differ in their ability to promote cell cycle arrest
demonstrated the correlation between Vpr-SLX4binding and the
G2/M arrest effect of Vpr (Berger et al., 2015).
DNA damage-binding (DDB) protein, which
constitutesDDB1 and DDB2 subunits, translocates to the
nucleus to mediate DNA repair in response to DNA damage
signal (Wittschieben and Wood, 2003; Iovine et al., 2011). The
formation of a complex comprising HIV-1 Vpr, DDB1-Cullin
4A-associated factor 1 (DCAF1), and DDB1 has been implicated
as the upstream event in Vpr-triggered G2/M arrest (Le Rouzic
et al., 2007; Schröfelbauer et al., 2007). It is known that Vpr
hampers the nuclear localization of DDB1, and interferes with
the binding of DDB1 to damaged DNA as detected by an
electrophoretic mobility shift assay (EMSA) (Schröfelbauer
et al., 2007). Moreover, the association of Vpr with DDB1
disrupts complex formation between DDB1 and DDB2, which
is a prerequisite for DNA repair (Schröfelbauer et al., 2007).
The significance of Vpr-DDB1 interaction in Vpr-mediated
cytostatic effect was revealed through the use of DDB1 binding-
deficient Vpr mutant (Schröfelbauer et al., 2007). It is worth
mentioning that one of the multiple functions of DDB1 is to act
as a component of an ubiquitin-E3 ligase complex that targets
cell cycle regulatory proteins such as p27KIP1 for proteasomal
degradation (Bondar et al., 2006). It will be of interests to
investigate whether the association of Vpr with DDB1 could
antagonize its role in the hydrolysis of p27KIP1 and other cell
cycle effectors, thus contributing to cell cycle arrest. Indirect
support for this hypothesis stems from experiments with
transient expression of HBV HBx, which induces accumulation
of lagging chromosomes and other mitotic aberrations, leading
to the activation of DNA replication checkpoint with a delayed
S phase progression (Martin-Lluesma et al., 2008). The use of
an HBx mutant that is deficient for DDB1 binding suggests
that this perturbation of cell cycle progression is attributable
to the interaction of HBx with DDB1 (Leupin et al., 2003;
Martin-Lluesma et al., 2008).
SUBVERSION BY PROTEIN
PHOSPHORYLATION (TABLE 2 AND
FIGURE 2)
Phosphorylation and dephosphorylation govern the function of
many cell cycle regulators, thus acting as switches to ensure its
normal progression. For instance, the kinase activity of CDK4
cannot be merely regulated by its association with D-type cyclin.
CDK4 phosphorylation onThr172 by CAK is also required to
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TABLE 2 | Cell cycle subversion by protein phosphorylation.
Virus/Genome Viral protein Host protein Functional consequence References
HIV-1/RNA plus Vpr Phosphorylation of Chk1 G2/M arrest Li et al., 2010
RVFV/RNA minus NS proteins Phosphorylation of ATM and Chk2 S phase arrest Baer et al., 2012
HBV/circular DNA Phosphorylation of Chk1 and p53 Transient cell cycle arrest in S and G2 phases Zhao et al., 2008
HSV-1/dsDNA ICP0 Phosphorylation of ATM and Chk2 CDK1 inactivation with ensuing G2/M arrest Ahn et al., 2000; Li et al., 2008
HHV-6/dsDNA UL24 family
protein
Phosphorylation of CDK1 G2/M arrest Nascimento et al., 2009; Li et al.,
2011
Reovirus/dsRNA sS1 Phosphorylation of CDK1 G2/M arrest Poggioli et al., 2000, 2001
HCMV/dsDNA IE1-72 Phosphorylation of E2Fs, p107, p130 Transcriptional activation, cell cycle progression Pajovic et al., 1997
HCMV/dsDNA UL97 Phosphorylation of Rab Phosphorylation and inactivation of Rab Hume et al., 2008
FIGURE 2 | Cell cycle subversion by protein phosphorylation. (A) Direct phosphorylation of Rb by HCMV UL97 protein dissociates E2F-Rb/p107 complexes releasing
E2F to activate transcription and cell cycle progression (Hume et al., 2008). HCMV IE1-72 is a viral protein kinase able to directly and selectively phosphorylate
transcription factors of the E2F family (E2F1,−2, and−3), leading to E2F-dependent transcriptional activation, thus regulating cell cycle events (Pajovic et al., 1997).
(B) Expression of viral S1 gene-encoded σ1s nonstructural protein during reovirus infection leads to G2/M arrest in host cells via σ1s-mediated CDK1
hyperphosphorylation (Poggioli et al., 2000, 2001). Similarly, human herpesvirus 6 (HHV-6)-induces G2/M arrest by increasing the inactive Ser216-phosphorylated
form Cdc25C phosphatase that accumulates in the cytoplasm where it has no access to its CDK1 substrate (Li et al., 2011). Members of herpesvirus share the
conserved UL24 family of proteins (i.e., UL24, ORF20, and UL76), whose expression induces CDK1 phosphorylation at Tyr15 inhibitory site with ensuing cell cycle
G2/M arrest (Nascimento et al., 2009). (C) HSV-1 immediate-early gene product ICP0 triggers a series of phosphorylation events resulting in cytoplasmic
sequestration of Cdc25C, which maintains high levels of CDK1 inhibitory phosphorylation, leading to CDK1 inactivation with ensuing G2/M arrest (Li et al., 2008).
catalyze the process (Kato et al., 1994). As another example, the
inhibitory effect of Rb on transcription factor E2F1is suppressed
through CDK4/6-mediated hyperphosphorylation of Rb (Sidle
et al., 1996). Not surprisingly, viruses have evolved mechanisms
to modulate phosphorylation and dephosphorylation events as
additional means to subvert host cell division cycle for their own
benefit.
Viral Kinases
Direct phosphorylation of Rb was reported for HCMV UL97
protein as the first example of a virus-encoded functional
ortholog of CDK (Hume et al., 2008). As expected, expression
of mutant UL97 in cells, which are intrinsically deficient in the
ability to phosphorylate Rb, induces Rb phosphorylation on the
inactivating residues. Moreover, UL97 rescues the proliferation
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of a yeast mutant which lacks CDK activity, suggesting UL97
functions similar to CDK. Sequence comparison between CDK
and UL97 revealed that this viral protein does not require cyclin
binding for kinase activity and, therefore, is resistant to the
inhibition of p21WAF1/CIP1, features which shield UL97 from the
normal cellular control mechanisms that could attenuate CDK
activity (Hume et al., 2008).
HCMV IE1-72 is a viral protein kinase, which is able
to directly and selectively phosphorylate transcription factors
of the E2F family (E2F1,−2, and−3) and pocket proteins
(p107 and p130) (Pajovic et al., 1997). Its kinase activity is
required for IE1-72-mediatedformation and/or dissociation of
inhibitory complexes that lead to E2F-dependent transcriptional
activation, thus regulating cell cycle events (Pajovic et al.,
1997). It is interesting to note that the kinase activity of IE1-
72 resides in the portion encoded by exon 4, which is not
the same region necessary for its binding to p107 (encoded
by exon 3) as mentioned above (Johnson et al., 1999). It
is possible that this interaction functions as the first step
to bridge IE1-72 to its target for later phosphorylation, or
that IE1-72 can independently exert its role in cell cycle
regulation through either physical interaction or its kinase
activity.
CDK1/Cdc25
Reovirus infection and the sole expression of viral S1 gene-
encoded σ1s nonstructural protein could lead to G2/M arrest
in host celosia σ1s-mediated CDK1 hyperphosphorylation
as revealed with the use of σ1s-mutant virus (Poggioli
et al., 2000, 2001). It was reported that the inhibitory
phosphorylation of CDK1 by reovirus decreased the
hyperphosphorylated form (active form) of Cdc25C, the
CDK1-specific phosphatase (Poggioli et al., 2001), hence
preventing CDK1 dephosphorylation, an absolute requirement
for the onset of mitosis (Jin et al., 1996). Similarly, human
herpesvirus 6 (HHV-6)-induced G2/M arrest correlates with
enhanced phosphorylation of CDK1 at the Tyr15 inhibitory
site. This is achieved through both elevating the level of the
negative regulator Wee1 and inhibiting the activity of Cdc25C
phosphatase by increasing the inactive Ser216-phosphorylated
form that accumulates in the cytoplasm where it has no access
to its CDK1 substrate (Li et al., 2011). Members of herpesvirus
share the conserved UL24 family of proteins, namely UL24 in
herpes simplex virus type 1 (HSV-1), ORF20 in KSHV, and
UL76 in HCMV. Expression of these UL24 proteins led to CDK1
phosphorylation at Tyr15, the dephosphorylation of which is
required for the initiation of mitosis (Jin et al., 1996), with
ensuing cell cycle G2/M arrest (Nascimento et al., 2009). Similar
observations were made with murine gammaherpesvirus 68
(MHV68) infection (Nascimento and Parkhouse, 2007).
The expression of HSV-1 immediate-early gene product ICP0
in HEK 293T cells activates Chk2, but not Chk1, through
Thr68 phosphorylation (Li et al., 2008). This activation relies
on ICP0-dependent phosphorylation of ataxia telangiectasia
mutated (ATM), an upstream effector kinase of Chk2 (Ahn
et al., 2000), as revealed in ATM-deficient cell lines (Li
et al., 2008). Activated Chk2 in turn phosphorylates Cdc25
on Ser216, which promotes binding of the molecule to 14-3-
3 proteins, resulting in cytoplasmic sequestration of Cdc25C,
as discussed above, which maintains high levels of CDK1
inhibitory phosphorylation (Matsuoka et al., 1998; Graves
et al., 2001). The requirement for the kinase activity of
Chk2 in ICP0-induced inhibitory-phosphorylation of Cdc25C
was demonstrated by reconstituting Chk2-deficient cells with
kinase-defective mutant form of Chk2 (Li et al., 2008). Thus,
through serial phosphorylation events, ICP0 leads to CDK1
inactivation with ensuing G2/M arrest. Similarly, ATM and
Chk2 phosphorylation are required for Rift Valley fever virus
(RVFV)-induced S phase arrest, a phenomenon attributed
to the activity of viral nonstructural proteins (Baer et al.,
2012).
Infection of a hepatocyte cell line with HBV
causes phosphorylation of Chk1 and p53at Ser345 and
Ser15respectively, which is accompanied by a transient cell
cycle arrest in S and G2 phases (Zhao et al., 2008). Although
more remains to be done to elucidate the signaling pathway
concerning these phosphorylation events, it is known that
Chk1 phosphorylation on Ser345 is essential for the activation
of checkpoint arrest in G2/M phase (Lopez-Girona et al.,
2001). Similarly, Chk1 phosphorylation at Ser345 is required
in G2/M arrest induced by HIV-1 Vpr as re-introduction
of a phosphorylation-resistant Chk1 mutant fails to restore
Vpr-induced G2/M arrest in Chk1-depleted cells (Li et al., 2010).
Thus, by phosphorylating Chk1, Vpr facilitates proteasome-
mediated degradation of Cdc25C and, to a lesser extent, Cdc25B,
contributing to G2/M arrest (Lopez-Girona et al., 1999; Graves
et al., 2001; Bulavin et al., 2003).
CDK2
CDKs remain catalytically inactive until cyclin-bound CDKs
undergo phosphorylation at Thr161/160/172 by CAK (Gould
et al., 1991; Norbury et al., 1991; Desai et al., 1992; Gu
et al., 1992; Krek and Nigg, 1992; Solomon et al., 1992).
The current model of CDK/cyclin activation posits two steps:
(i) formation of an intermediate complex composed by the
PSTAIRE helix of CDK2 and helices 3 and 5 of the cyclin;
(ii) isomerization of the CDK/cyclin complex to expose the T-
loop of CDK, which is then accessible to phosphorylation by
CAK to form the substrate binding site (Morris et al., 2002).
CDK2/CDK4 phosphorylation at their respective Thr sites by
CAK subunits, for example CDK7/cyclin H (Fisher and Morgan,
1994), is essential for both the stabilization of CDK/cyclin
complexes and could increase the flexibility of the CDK2 T-
loop (Matsuoka et al., 1994; Morris et al., 2002). Overexpression
of the ARV p17 protein inhibited CDK2 phosphorylation at
T160, which was dependent on CDK7/cyclin H disassociation
due to increased p53/cyclin H interaction (Chiu et al., 2018).
Thus, by diminishing the CAK activity, namely CDK7/cyclin H
association, p17 prevents CDK2 phosphorylation and therefore
inhibits its kinase activity. Although the mechanism of how
p17 diminishes CAK activity in a p53-dependent manner
remains to be elucidated, it is another example illustrating
how viruses regulate the cell cycle machinery (Chiu et al.,
2018).
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SUBVERSION BY PROTEIN DEGRADATION
(TABLE 3 AND FIGURE 3)
Proteolysis of cell cycle regulators at defined stages plays
a crucial role in cell cycle progression. While purified
recombinant IE2-86 of HCMV is able to block the inhibitory
effect of the cyclin-dependent kinase inhibitor p21WAF1/CIP1
through physical interaction as previously mentioned, HCMV
infection can also target p21WAF1/CIP1 todegradation. Thus, a
disparity between p21WAF1/CIP1 RNA and protein levels was
observed after HCMV infection, implying possible degradation
of p21WAF1/CIP1 in virus-infected cells (Chen et al., 2001).
Infection could induce sustained increase in calpain activity
and the use of specific inhibitors demonstrated that calpain,
and not proteasome activity is required for HCMV-mediated
p21WAF1/CIP1 reduction, although the molecular mechanism by
which p21WAF1/CIP1 is targeted by calpain is not clear (Chen et al.,
2001).
The interaction between cyclin D3 and M2 during Influenza
A infection provides another example of the involvement of
the proteasomal degradation pathway. Although the interaction
was found to inhibit virus production, this mode of restriction
eventually surrenders to viral infection as cyclin D3 becomes
trapped in the cytoplasm by M2 and eventually undergoes
proteasomal degradation upon prolonged infection (Fan et al.,
2017). Indeed, mislocalization and subsequent downregulation
of restriction factors is one of the recurring mechanisms
viruses have adopted to overcome host defenses (Ma et al.,
2012). In the case of IAV, two possible mechanisms account
for the relocalization of cyclin D3 to the cytoplasm: (i) M2
interacts with newly synthesized cyclin D3 and prevents it from
translocating into the nucleus, or (ii) cyclin D3 is retained
by M2 in the cytoplasm after its nuclear export. It will be
interesting to explore thesemechanisms in greater detail in future
studies.
HIV-1 viral infectivity factor (Vif) binds to the central domain
of mouse double-minute 2 protein (MDM2), the primary E3
ubiquitin ligase for p53 (Momand et al., 2000; Izumi et al.,
2009). Izumi et al. showed that expression of Vif could block
MDM2-mediated proteasomal degradation of p53, leading to
cell cycle arrest in G2 (Izumi et al., 2010). More interestingly,
the same study reported that Vif could directly interact with
p53, independent of its association with MDM2, leading to a
partial blockage of p53-MDM2 binding and, hence, impairment
of MDM2-mediated p53 degradation. This strategy appears
to be very effective and economical, as it has been adopted
by other viruses. For example, the IAV nucleoprotein (NP)
binds to p53 with ensuing protein stabilization as a result of
compromised MDM2-mediated p53 degradation (Wang et al.,
2012). ARV infection promotes p53 phosphorylation at multiple
sites, an event which alleviates p53 inhibition by MDM2 (Shieh
et al., 1997), and activates the transcriptional function of p53
(Lin et al., 2009). It was later discovered that p17 protein
of ARV could robustly enhance MDM2 binding to ribosomal
proteins, thereby blocking MDM2-mediated p53 ubiquitination
and degradation (Zhang and Lu, 2009; Huang et al., 2017).Thus,
through multiple mechanisms, ARV impairs the ability of
MDM2 to target p53 for degradation. There is evidence that
both PTEN and p21WAF1/CIP1 are required for p53-mediated
cell cycle arrest (el-Deiry et al., 1993; Stambolic et al., 2001),
which is dependent on a complex signaling cascade that brings
about Akt-induced phosphorylation of MDM2, antagonized by
PTEN, and the ensuing translocation of MDM2 to the nucleus
to downregulate p53 (Mayo and Donner, 2002). Thus, the
interplay between viruses and tumor suppressor proteins is
likely to target multiple networks that ultimately affect the cell
cycle.
The anaphase promoting complex/cyclosome (APC/C) was
characterized as a securin- and cyclin B-specific ubiquitin
ligase, functioning mainly to trigger metaphase to anaphase
transition by tagging these proteins for degradation (Irniger
et al., 1995; King et al., 1995; Sudakin et al., 1995; Thornton
and Toczyski, 2003; Peters, 2006). Securin sequesters separin,
the “sister-separating” protease, preventing the separation and
segregation of sister chromatids (Nasmyth et al., 2000; Yanagida,
2000). Thus, the degradation of securin by APC/C is essential
for the completion of mitosis, leading to correct transmission
of chromosomes from mother to daughter cells (Zou et al.,
1999).The oncoprotein Tax of HTLV-1 is able to promote
securin and cyclin B1 degradation, a process which requires
the function of the accessory factor CDC20 of APC, leading
to chromosome instability (Liu et al., 2003). Although the
mechanism by which Tax activates APC is still unclear, an
association of Tax with APCCDC20 was reported (Liu et al., 2005).
Interestingly, premature activation of APC by Tax could also
result in a surge in the levels of p21WAF1/CIP1 and p27KIP1,
leading to G1 arrest that resembles cellular senescence (Kuo and
Giam, 2006). This was found to be a result of polyubiquitination
and degradation of Skp2, the substrate recognition subunit of
the SCFSkp2 E3 ubiquitin ligase that regulates the destruction
of p21WAF1/CIP1 and p27KIP1, by Tax-activated APC (Carrano
et al., 1999; Nakayama et al., 2004; Kuo and Giam, 2006). Thus,
by targeting the E3 ligase of p21WAF1/CIP1 and p27KIP1 for
degradation, Tax stabilizes these two CKIs. On the contrary, the
association of chicken anemia virus protein Apoptin with APC1
inhibits the activity of theAPC/C ubiquitin ligase, leading to
the stabilization of cyclin B1 and other APC/C substrates, with
ensuing cell cycle G2/M arrest and apoptosis (Teodoro et al.,
2004).
The deubiquitinase (DUB) USP37 has been found to stabilize
cyclin A by removing the polyubiquitin from the latter and,
hence, accelerates entry into S phase (Huang et al., 2011). HBx
of HBV could upregulate USP37 transcripts in both hepatic and
non-hepatic cells and also prevents USP37 from proteasomal
degradation. HBx acts as a chaperone of USP37 and shuttles it
out of the nucleus, where the ubiquitin E3 ligase CDC20 homolog
1 (CDH1) and b-TrCP associate with USP37 (Zhou et al., 2003;
von Mikecz, 2006; Saxena and Kumar, 2014). Thus, by stabilizing
the expression of USP37, HBx promotes the accumulation of
cyclin A to modulate cell cycle progression. Furthermore, HBx
hinders the proteolytic cleavage of Notch1, which plays a critical
role in proliferation (Artavanis-Tsakonas et al., 1999; Wang et al.,
2010; Xu et al., 2010). This is achieved through HBx-mediated
transcriptional downregulation of presenilin 1, a catalytic subunit
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TABLE 3 | Cell cycle subversion by protein degradation.
Virus/Genome Viral protein Host protein Functional consequence References
HTLV-1/RNA plus Tax Association with accessory factor
CDC20 of APC
Activation of anaphase promoting complex Liu et al., 2005
HTLV-1/RNA plus Tax Polyubiquitination and degradation
of Skp2
Stabilization of p21WAF1/CIP1 and
p27KIP1 CKIs, cell cycle G1 arrest
Carrano et al., 1999;
Nakayama et al., 2004;
Kuo and Giam, 2006
HIV-1/RNA plus Vif Inhibition of p53 ubiquitination and
degradation
Cell cycle arrest in G2 Izumi et al., 2010
HBV/circular DNA HBx Upregulation of USP37 transcripts Accumulation of cyclin A and acceleration
of the G1/S phase transition
Saxena and Kumar, 2014
HBV/circular DNA HBx Reduction of Notch cleavage Induction of G1-S cell cycle progression Wang et al., 2010; Xu
et al., 2010
HSV-1/dsDNA ICP0 CENP-C, CENP-A proteasome
degradation
Mitotic block Everett et al., 1999;
Lomonte et al., 2001
Japanese Encephalitis
virus/RNA plus
Degradation of p21WAF1/CIP1 and
p27KIP1 CKIs
Bypass G0/G1 arrest Das and Basu, 2008
EV71/RNA plus Cyclin A2 proteasome degradation Prevent cell cycle transition from S to
G2/M phase
Ooi et al., 2007; Yu et al.,
2015
Influenza A/RNA minus M2 Cyclin D3 Cell cycle arrest in G0/G1 Fan et al., 2017
Influenza A/RNA minus Nucleoprotein (NP) Inhibits MDM2-mediated p53 degradation;
apoptosis
Wang et al., 2012
HCMV/dsDNA Calpain-dependent p21WAF1/CIP1
degradation
Impaired cell cycle arrest in G2 Chen et al., 2001
Avian Reovirus/dsRNA P17 Phosphorylation of p53 Prevents MDM2-mediated p53
degradation; cell cycle arrest
Lin et al., 2009
of the large protease complex γ-secretase which mediates the
cleavage of Notch 1 (Artavanis-Tsakonas et al., 1999; Kopan and
Ilagan, 2009; Xu et al., 2010).
In addition to hijacking the host ubiquitination machinery,
viruses could also encode their own degradation enzymes. The
zinc-binding RING finger domain of ICP0 of HSV-1 possesses
a ubiquitin E3 ligase activity (Boutell et al., 2002; Hagglund
et al., 2002). Sole expression of ICP0 is able to induce rapid
loss of the centromeric protein CENP-C and CENP-A in
a proteasome-dependent manner, resulting in mitotic block
(Everett et al., 1999; Lomonte et al., 2001). However, it remains
unclear whether these two centromere components are direct
substrates of the ICP0 E3 ligase. The use of purified p53 in
the presence of ICP0, together with a full complement of the
ubiquitin-conjugating enzymes in test tubes, revealed a direct
ubiquitination of p53 by ICP0 (Boutell and Everett, 2003); p53
levels, howver, were not reduced during HSV-1 infection and,
hence, the role of p53 in ICP0-induced perturbation of cell cycle
progression and accumulation in G1/S and G2/M needs further
investigation (Hobbs and DeLuca, 1999). Still, it provides a novel
mechanism by which a virus-encoded protein functions as an
E3 ligase to catalyze the degradation of cell cycle checkpoint
proteins.
Acute Japanese encephalitis virus (JEV) infection leads to
cell cycle G0/G1 arrest with elevated p21WAF1/CIP1 and p27KIP1
levels, and reduced production of cyclin D (Das and Basu, 2008).
However, in the case of persistent JEV infection, expression of
these CKIs and GSK-3β, which mediates the degradation of
cyclin D, is suppressed (Diehl et al., 1998; Kim et al., 2015).
Thus, by extending the stability of cyclin D, persistent JEV
infection bypasses cell cycle arrest, striking a balance between the
persistence of lytic RNA virus and host survival. Enterovirus 71
(EV71), the etiological agent of hand, foot, and mouth disease,
was shown to prevent cell cycle transition from S to G2/M
phase (Ooi et al., 2007; Yu et al., 2015). Although the molecular
mechanisms is still unclear, it was observed that cyclin A2 was
targeted for proteasome-mediated degradation during infection
(Yu et al., 2015).
SUBVERSION BY PROTEIN
REDISTRIBUTION (TABLE 4 AND
FIGURE 4)
While it is well established that several biochemical processes
serve to orchestrate cell cycle control, including protein-
protein interaction and dissociation, phosphorylation/
dephosphorylation, and the synthesis/ destruction of cell
cycle regulators at specific time point, the importance of
subcellular localization of CDK-cyclins complexes and their
regulators is receiving increasing attention for proper cell-cycle
coordination. Hence, viruses have also evolved mechanisms to
deregulate cell cycle progression by targeting the localization of
cell cycle regulators.
One early example of virus-induced translocation of cell
cycle regulators is exemplified by HCMV infection, which can
mitogenically stimulate growth-arrested cells to enter the cell
cycle by promoting nuclear uptake of CDK2 (Bresnahan et al.,
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FIGURE 3 | Cell cycle subversion by protein degradation. (A) Expression of (Vif) protein of HIV-1 blocks MDM2-mediated proteasomal degradation of p53, by binding
to both MDM2 and p53, leading to cell cycle arrest in G2 (Izumi et al., 2010). (B) The degradation of securin by the anaphase promoting complex/cyclosome (APC/C)
is essential for the completion of mitosis, leading to correct transmission of chromosomes from mother to daughter cells. The oncoprotein Tax of HTLV-1 is able to
promote securin and cyclin B1 degradation, leading to chromosome instability (Liu et al., 2003). (C) ICP0 of HSV-1 possesses an ubiquitin E3 ligase activity (Boutell
et al., 2002; Hagglund et al., 2002), which results in rapid loss of the centromeric protein CENP-C and CENP-A in a proteasome-dependent manner and mitotic block
(Everett et al., 1999; Lomonte et al., 2001). However, it remains unclear whether these two centromere components are direct substrates of the ICP0 E3 ligase
(dashed line). Likewise, ICP0 can directly ubiquitinate p53 (Boutell and Everett, 2003), although p53 levels are not reduced during HSV-1 infection (Hobbs and
DeLuca, 1999) and, hence, the role of p53 in ICP0-induced perturbation of cell cycle progression remains unclear (dashed line).
1997). This suggests that HCMV possesses mechanisms to
regulate the subcellular distribution of CDK2, thus facilitating
the activation of cyclin E-CDK2 complex and, consequently,
modulating cell cycle progression. It is possible that CDK2
could be transported into the nucleus in a “piggyback”
manner, interacting with a viral protein that shuttles between
nucleus and cytoplasm, or that viral infection activates the
intrinsic CDK2 import machinery. Indeed, infection of primary
erythroid progenitor cells by human parvovirus B19 (B19V)
leads to G2 arrest, which is dependent on viral nonstructural
protein 1 (NS1), as its sole expression could recapitulate
the same phenomenon (Wan et al., 2010). The cell cycle
perturbation effect results from NS1-mediated downregulation
of activating E2Fs transcription factors (E2F1 to E2F3a) and
upregulation of repressive E2Fs (E2F4 to E2F8). Interestingly,
co-immunoprecipitation experiments in NS1 expressing cells
identified NS1-E2F4 and NS1-E2F5 complexes, which could
enhance the nuclear import of these transcription-repressive
factors. Normal cell cycle progression was observed in cells
infected with a mutant B19V, which encodes a nuclear-
localization-deficient NS1, demonstrating the importance of
NS1-mediated redistribution of E2F4 and E2F5 in causing cell
cycle perturbation (Wan et al., 2010).
For cyclin D3 to exert its effect in cell cycle G0/G1
progression, it needs to be transported from the cytoplasm to
the nucleus (Mahony et al., 1998). It was demonstrated through
confocoal imaging and subcellular fractionation assay that, in
influenza A virus infected cells, cyclin D3 was significantly
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TABLE 4 | Cell cycle subversion by protein redistribution.
Virus/Genome Viral protein Host protein Functional consequence References
HIV-1/RNA plus Vpr 14-3-3σ scaffolding protein,
MAPKAP kinase-2
Sequestration of Cdc25C in cytoplasm, G2/M arrest Kino et al., 2005; Bolton et al.,
2008; Huard et al., 2008
HIV-1/RNA plus Vif CDK1, cyclin B1 Cytoplasmic retention, G2/M arrest Sakai et al., 2011
HHV-6-HHV8/dsDNA E2F1 Accumulation in cytoplasm, reduction of E2F1-Rb
complexes and cell cycle arrest
Mlechkovich and Frenkel, 2007;
Sharon et al., 2014
Influenza A/RNA minus M2 Cyclin D3 Redistribution of cyclin D3 from the nucleus to the
cytoplasm; cell cycle arrest in G0/G1
Fan et al., 2017
HCMV/dsDNA CDK2 Nuclear translocation, mitogenic Bresnahan et al., 1997
HCMV/dsDNA NS5A p53 Reduced nuclear translocation, ant-apoptotic Kovacs et al., 1996; Fortunato
and Spector, 1998; Majumder
et al., 2001
Parvovirus B19/ssDNA NS1 E2F4-8 repressive
transcription factors
Nuclear import and G2 arrest Wan et al., 2010
Epstein-Barr/dsDNA LMP1 Survivin, p53 Increased nuclear localization Guo et al., 2012
Avian Reovirus/dsRNA P17 CDK1 Cytoplasmic retention Chiu et al., 2018
redistributed from the nucleus to the cytoplasm, followed by
its proteasomal degradation (Fan et al., 2017). Hence, through
multiple mechanisms, influenza A virus perturbs cell cycle
progression for enhanced progeny virus production. Similarly,
a significant increase in the cytoplasmic level of CDK1 was
observed in ARV-infected or p17-expressing cells (Chiu et al.,
2018). Thus, p17 of ARV not only perturbs cell cycle progression
into mitosis through direct inhibition of CDK1 kinase activity,
but also disrupts CDK1/cyclin B1 complex formation in the
nucleus by sequestering CDK1 in the cytoplasm. Although total
p53 levels were elevated after infection, a reduction of p53 level
in nuclear extracts of HCMV-infected human umbilical vein
endothelial cells was observed, resulting in an anti-apoptotic
phenotype of HCMV-infected cells (Kovacs et al., 1996). The
reduced nuclear-translocation of p53 by HCMV, as suggested
by immunofluoresence, provides a plausible explanation for the
oncogenic potential of HCMV (Kovacs et al., 1996). Wang
et al. later reported that the cytoplasmic sequestration of p53
by HCMV occurs by blocking the nuclear localization signal
(NLS) of p53 (Wang et al., 2001). Interestingly, in addition to
perturbing the nuclear-import of p53, HCMV could also inhibit
the function of nuclear p53 through sequestering it into discrete
foci, viz., the replication centers, within the nuclei of HCMV-
infected cells (Fortunato and Spector, 1998). Changes in the
subcellular localization of p53 were also observed in two different
cell lines that expressed the HCVNS5A protein (Majumder et al.,
2001). Endogenous p53 is a nuclear protein, whereas it was
retained at the perinuclearmembrane followingNS5A expression
(Shaulsky et al., 1991). A physical association of NS5A with
p53 was demonstrated both in vitro and in vivo; however, it is
not the cause for this sequestration as NS5A binding-deficient
p53 was still observed to localize on the perinuclear membrane.
In accordance, hTAFII32, a transcriptional coactivator of p53,
was also partially sequestered by NS5A in the cytoplasm, thus
suggesting an indirect mechanism (Lu and Levine, 1995; Lan
et al., 2002). Although p53 is known as a tumor suppressor
gene, increasing evidence suggest that nasopharyngeal carcinoma
(NPC) is associated with overexpression and accumulation of
p53 (Gulley et al., 1998; Yip et al., 2006). It is interesting to
find that the late membrane protein 1 (LMP1) of EBV not
only upregulates the expression and phosphorylation of p53
and survivin, which possesses a p53-binding element in its
promoter region and facilitates G1/S progression by interacting
with CDK4 in the nucleus (Suzuki et al., 2000; Hoffman
et al., 2002; Mirza et al., 2002; Guo et al., 2012), but also
increases the nuclear localization of both proteins (Guo et al.,
2012).
Expression of HIV-1 Vpr could induce localized-disruption
in the lamin architecture, which is known to interfere with
DNA synthesis and changes in the intracellular trafficking of
cell cycle regulators (Moir et al., 2000; de Noronha et al., 2001).
This structural defect of lamin leads to the formation of nuclear
envelope herniations as revealed by immunofluorescence,
resulting in changes in the subcellular compartmentalization
of Cdc25C, cyclin B1, and Wee1 (de Noronha et al., 2001).
Thus, interaction of HIV-1 Vpr with the 14-3-3σ scaffolding
protein, a G2/M transition regulator that inactivates Cdc25C by
changing its subcellular localization and/or stability (Fu et al.,
2000; Muslin and Xing, 2000), has been implicated in Vpr-
induced cell cycle perturbation (Peng et al., 1997; Lopez-Girona
et al., 1999; Laronga et al., 2000; Kino et al., 2005). Vpr could
mediate protein assembly among 14-3-3σ, Cdc25C, CDK1, and
cyclin B1, leading to G2/M arrest by either sequestering Cdc25
in the cytoplasm or impairing the normal association of 14-3-
3σ with centrosomal proteins (Kino et al., 2005; Bolton et al.,
2008). An association of Vpr with MAPKAP kinase-2 (MK2),
a possible regulatory kinase of Cdc25, was reported by Huard
et al. (2008). Although the relevance of this interaction in Vpr-
mediated cell cycle arrest needs further investigation, it appears
that MK2 is required for Vpr-induced Cdc25 phosphorylation
and nuclear export (López-Avilés et al., 2005; Manke et al., 2005;
Huard et al., 2008). The accessory protein viral infectivity factor
(Vif) of HIV-1 also inhibits cell cycle progression at the G2
phase by interfering with the nuclear translocation of CDK1
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FIGURE 4 | Cell cycle subversion by protein redistribution. (A) Nonstructural protein 1 (NS1) of human parvovirus B19 (B19V) leads to G2 arrest, which is mediated by
upregulating nuclear localization of repressive E2F4 and E2F5 transcription factors (Wan et al., 2010). (B) Cyclin D3 needs to be imported into the nucleus to assist
G0/G1 cell cycle progression (Mahony et al., 1998). Influenza A virus infection perturbs cell cycle progression by redistributing cyclin D3 from the nucleus to the
cytoplasm, triggering its proteasomal degradation (Fan et al., 2017). (C) Expression of HIV-1 Vpr induces localized-disruption in the lamin architecture, resulting in
G2/M arrest that is dependent on cytoplasmic compartmentalization of Cdc25C, cyclin B1, and Wee1 (Peng et al., 1997; Laronga et al., 2000; de Noronha et al.,
2001; Kino et al., 2005).
and cyclin B1, a finding corroborated by infection experiments
with Vif-deficient HIV-1 virus that point to a role of this viral
protein in mediating CDK1 cytoplasmic-retention (Sakai et al.,
2011).
HHV-6A and HHV-6B provide other examples of
mislocalization coupled to cell cycle arrest, as their infection
reduces E2F1-Rb complex formation and leads to accumulation
of E2F1 both in the cytoplasmic and nuclear fractions, as opposed
to its strict nuclear localization in normal cells (Mlechkovich and
Frenkel, 2007). Although the relevance of E2F1 translocation in
HHV-6-induced cell cycle arrest is not completely understood, it
illustrates that viruses could also target E2F family of protein in
this context (Sharon et al., 2014).
SUBVERSION BY VIRUS-ENCODED
HOMOLOGS OF CELL CYCLE
REGULATORS (TABLE 5 AND FIGURE 5)
Herpesvirus saimiri (HVS), a T-lymphotropic gamma-
herpesvirus that establishes persistent conditions in primate
host species, encodes the first reported viral-cyclin (v-cyclin)
(Nicholas et al., 1992; Fickenscher and Fleckenstein, 2001).
Similarly, amino acid and DNA sequence analyses of KSHV,
which has been strongly implicated as the etiologic factor in
the development of Kaposi’s sarcoma and primary effusion
lymphomas (PEL) (Chang et al., 1994; Cesarman et al., 1995),
identified a “cyclin-box” showing similarity to human cyclin
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TABLE 5 | Cell cycle subversion by virus-encoded homologs of cell cycle regulators.
Virus/Genome Viral protein Host protein Functional consequence References
Herpesvirus saimiri,
KSHV/dsDNA
Viral cyclins CDK6 Rb and H1 phosphorylation; CAK-independent
activation of CDK6
Jung et al., 1994; Godden-Kent
et al., 1997; Li et al., 1997;
Swanton et al., 1997; Kaldis, 1999
MHV68/dsDNA Viral cyclin CDK2 Phosphorylation of p27KIP1 to bypass G1 arrest Virgin et al., 1997; Card et al., 2000
KSHV/dsDNA Viral cyclin p27KIP1 Phosphorylation-dependent degradation, cell cycle
progression
Vlach et al., 1997; Mann et al.,
1999; Zhi et al., 2015
Autographa californica
nucleopolyhedrovirus /dsDNA
IE2, occlusion-derived
viral form-EC27
CDK6, CDK1 Rb phosphorylation, G2/M cell cycle arrest Belyavskyi et al., 1998; Braunagel
et al., 1998; Prikhod’ko and Miller,
1998
Walleye dermal sarcoma
virus/RNA plus
Retroviral cyclins CDK8, CDK3 Cell proliferation LaPierre et al., 1998; Brewster
et al., 2011
Poxviruses/dsDNA Poxvirus APC/cyclosome
regulator
APC2 scaffold
protein
Impairment of APC/C function, accumulation of
cells in G2/M
Mo et al., 2009
FIGURE 5 | Cell cycle subversion by virus-encoded homologs of cell cycle regulators. (A) Several gammaherpesviruses encode viral-cyclins (v-cyclin) (Nicholas et al.,
1992; Chang et al., 1994, 1996; Cesarman et al., 1995; Li et al., 1997; Virgin et al., 1997; Fickenscher and Fleckenstein, 2001) that display strong association with
CDK6, leading to the phosphorylation of Rb and histone H1. (Bi) V-cyclin-CDK complexes are significantly more resistant to the inhibition imposed by p21WAF1/CIP1,
p27KIP1, and p16INK4A than cyclin D1-CDK complexes in vitro (Swanton et al., 1997). Failure or weak association of p21WAF1/CIP1 and p27KIP1 with v-cyclin likely
defines the inefficiency of these CKI to inhibit them (Swanton et al., 1997; Schulze-Gahmen et al., 1999; Card et al., 2000). (Bii) Higher affinity of v-cyclin for CDK6
than p16INK4A may prevent its displacement by p16INK4A. (C) Both crocodile and squirrel poxviruses encode the APC/cyclosome regulator (PACR), which shares
sequence similarities to the APC subunit 11 (APC11). PACR mimics the binding ability of APC11 to APC2 but not the ubiquitin ligase activity of APC11. Thus, poxvirus
hinders normal cell cycle progression by encoding an inactive homolog of APC11 (Mo et al., 2009).
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D2 (Chang et al., 1996; Li et al., 1997). In addition, murine
gammaherpesvirus 68 (MHV68), another member of the
gammaherpesviruses, shares with HVS and KSHV similarities
in the sequence of an open reading frame that is predicted to
encode a D-type cyclin (Virgin et al., 1997). Taken together,
these findings argue for a conserved role of these v-cyclins
in gammaherpesvirus biology. Indeed, both HVS and KSHV
v-cyclins show strong association with CDK6, leading to the
phosphorylation of Rb and histone H1 (Jung et al., 1994; Li et al.,
1997). Surprisingly, despite the fact that v-cyclin of MHV68
displays only around 20% similarity to cyclin A/E, it associates
with CDK2 rather than CDK6 (Card et al., 2000). Herpesvirus
ateles (AtHV-2) causes lethal lymphomas in various new world
primates and is closely related to HVS. The light DNA segment
of AtHV-2 possesses an open reading frame which shows
significant homology to D-type cyclins although its function was
not studied in molecular terms (Albrecht, 2000).
Interestingly, unlike D-type cyclins that have broad
association with different CDKs, the v-cyclins of HVS and
KSHV bind almost exclusively to CDK6 (Godden-Kent et al.,
1997). Of note, KSHV-cyclin can activate CDK6 independent
of phosphorylation by CAK in vitro and in vivo (Kaldis, 1999).
Moreover, the kinase activity of v-cyclin-CDK6 appears to be
much stronger than cyclin D1-CDK6, targeting also histone
H1, which is a preferred substrate of CDK2 rather than CDK6
(Alexandrow and Hamlin, 2005). This finding suggests a
transformation potential of v-cyclin through “hyperactivation”
of CDK6 (Jung et al., 1994; Swanton et al., 1997). In fact, ectopic
expression of KSHV v-cyclin abolishes the cell cycle arrest effect
imposed by Rb, which is related to Rb hyperphosphorylation
and functional inactivation (Chang et al., 1996). In support
of these finding, MHV v-cyclin-transgenic mice display a
significant increase in thymocyte number with promoted cell
cycle progression and also develop high-grade lymphoblastic
lymphoma (van Dyk et al., 1999).
Furthermore, the v-cyclin-CDK complexes are significantly
more resistant to the inhibition imposed by p21WAF1/CIP1,
p27KIP1, and p16INK4A than cyclin D1-CDK complexes in vitro
(Swanton et al., 1997). Lack or weak association of p21WAF1/CIP1
and p27KIP1 with v-cyclin likely defines the inefficiency of these
CKI to inhibit them (Swanton et al., 1997; Schulze-Gahmen et al.,
1999; Card et al., 2000). It is currently unclear how v-cyclins
antagonize the inhibitory effect of p16INK4A since this CKI acts
by inhibiting the catalytic subunit of CDK4 and CDK6 (Sherr
and Roberts, 1999). One hypothesis is that higher affinity of v-
cyclin for CDK6 than p16INK4A may prevent its displacement
by p16INK4A. Deletion of the p16INK4A locus was identified in
KSHV associated PEL primary samples, suggesting that loss
of p16INK4A may be another mechanism of KSHV-induced
transformation (Platt et al., 2002). In addition, by targeting
p27KIP1 to phosphorylation-dependent degradation, the v-cyclin
of KSHV could prevent the G1 arrest induced by the viral latency
protein vFLIP, which is co-translated from the same viral mRNA
as v-cyclin (Vlach et al., 1997; Mann et al., 1999; Zhi et al., 2015).
This was also demonstrated by the inability of KSHV v-cyclin to
escape p27KIP1 mediated cell cycle arrest when p27KIP1 is mutated
to a form that cannot be phosphorylated. Moreover, p27KIP1
phosphorylation on Ser10 by KSHV v-cyclin-CDK6 complex
enhances its cytoplasmic dislocation, which serves as another
means to facilitate cell cycle progression (Boehm et al., 2002;
Ishida et al., 2002; Sarek et al., 2006). Similarly, CDK2 associated
with v-cyclin of MHV68 exhibits substantial resistance to both
p21WAF1/CIP1 and p27KIP1, while inducing phosphorylation of
p27KIP1 to overcome p27KIP1-mediated G1 arrest (Yarmishyn
et al., 2008). However, v-cyclin of MHV68 is only able to
subvert p27KIP1-imposed G1 arrest, but not that imposed by
p21WAF1/CIP1 (Yarmishyn et al., 2008).
Autographa californica nucleopolyhedrovirus (AcMNPV)
infects pest insect and causes cycle arrest at G2/M phase
in host cells with continuing viral DNA replication
(Braunagel et al., 1998). Sole expression of the IE2 protein
of AcMNPV results in accumulation of enlarged cells with
DNA content greater than 4N (Prikhod’ko and Miller,
1998). More interestingly, the structural protein occlusion-
derived viral form (ODV)-EC27 is endowed with cyclin-like
activity, making it the second viral-encoded cyclin homolog
reported (Belyavskyi et al., 1998). Similar to the v-cyclins of
herpesviruses, association of ODV-EC27 with CDK6 leads to
Rb phosphorylation (Huard et al., 2008). Additionally, ODV-
EC27 was found to interact with CDK1, exerting cyclin B-like
activity.
Walleye dermal sarcoma virus (WDSV) and walleye
epidermal hyperplasia virus (WEHV) are retroviruses that
encode human D-type cyclin homologs. A standard yeast
complementation assay showed that the retroviral-cyclins
(rv-cyclins) of WDSV, but not that of WEHV, induce cell cycle
progression in G1-cyclin-deficient yeast (LaPierre et al., 1998).
In addition to sharing sequence similarity with D-type cyclins,
WDSV rv-cyclin was shown to be a structural ortholog of
cyclin C (Brewster et al., 2011), which was identified owing to
its ability to rescue cyclin G1 function in yeast (Huard et al.,
2008). Cyclin C has been shown to promote G0/G1 transition
through phosphorylating Rb in combination with CDK3 (Lew
et al., 1991; Ren and Rollins, 2004) and was later recognized
as part of the Mediator complex, which links gene-specific
activators to the general RNA Pol II transcription machinery, in
complex with CDK8 (Tassan et al., 1995; Conaway and Conaway,
2011; Malumbres, 2014). As expected, WDSV rv-cyclin has
been shown to interact with either CDK8, component of the
Mediator complex (Rovnak and Quackenbush, 2002; Poss et al.,
2013), or CDK3, leading to enhanced host gene expression
or cell proliferation without serum stimulation, respectively
(Brewster et al., 2011). Other viruses have been shown to interact
with subunits of the Mediator complex, but they are doing so
independently of viral cyclins. For example, varicella-zoster
virus (VZV), an alpha-herpes virus that causes varicella and
zoster, targets the MED25 subunit of Mediator through its major
transactivator protein, immediate early gene 62 (IE62) (Yang
et al., 2008), whereas herpes simplex virus utilizes VP16, which
controls the transcription of immediate early genes, to activate
transcription through a specific MED25-associated mediator
deficient in CDK8 (Uhlmann et al., 2007). Interestingly, it was
later found that CDK8 could positively regulate VP16-dependent
transcriptional regulation, while CDK11 and CDK19 exhibit
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opposing roles (Furumoto et al., 2007; Tsutsui et al., 2008,
2011).
Sequence analysis of available poxvirus genome has revealed
that both crocodile and squirrel poxviruses encode a RING-H2
protein, the poxvirus APC/cyclosome regulator (PACR),which
shares sequence similarities to the APC subunit 11 (APC11).
Together with the scaffold protein APC2, APC11 forms the
catalytic core of APC/C, which regulates the progression through
mitosis by targeting several anaphase inhibitory proteins for
proteolysis and the maintenance of G1 phase (Tang et al., 2001;
Hsu et al., 2002; Song et al., 2004; Wei et al., 2004; Wehman
et al., 2007; Mo et al., 2009). Interestingly, PACR mimics the
binding ability of APC11 to APC2 but not the ubiquitin ligase
activity of APC11. Expression of PACR impairs APC/C function,
accompanied by the accumulation of cells in G2/M phase. The
cell cycle perturbation effect of PACR requires its N-terminal
region, which is also the region responsible for association
with APC2 (Mo et al., 2009). Thus, poxvirus hinders normal
cell cycle progression by encoding an inactive homolog of
APC11.
SUBVERSION BY OTHER MECHANISMS
(TABLE 6)
HIV-1 Vpr-induced G2 arrest depends on the activation of
ATR, the ataxia telangiectasia mutated (ATM)- and Rad3-related
protein, which phosphorylates Chk1 and, in turn, leads to both
phosphorylation-induced degradation of Cdc25A and Cdc25C
cytosolic sequestration (Peng et al., 1997; Sanchez et al., 1997;
Zhao and Piwnica-Worms, 2001; Zhao et al., 2002; Roshal et al.,
2003). It has been proposed that the activation of ATR-dependent
DNA damage G2/M checkpoint by Vpr involves the direct
binding of this viral protein to chromatin, as mutants which are
unable to bind chromatin fail to activate ATR (Lai et al., 2005),
although the underlying mechanism remains controversial. Lai
et al. reported that Vpr does not induce DNA double-strand
breaks (DSBs), but increases the association of replication protein
A (RPA) with chromatin, an upstream event required for ATR
activation (Cortez et al., 2001; Zou and Elledge, 2003; Lai et al.,
2005). However, using the same pulsed-field gel electrophoresis
assay, Tachiwana et al. later showed that Vpr expression could
induce chromosomal DSBs (Tachiwana et al., 2006). Differences
in experimental settings may underpin this discrepancy. Lai et al.
relied on Vpr-transfected cells for the PFGE analysis, whereas
isolated nuclei that were treated with purified Vpr were used in
the other study. The NS1 of the autonomous parvovirus minute
virus of mice (MVMp) is another example of viral protein that
affects the integrity of chromatin. MVMp infection leads to cell
cycle arrest in S phase as a result of NS1-induced nicks in the
cellular chromatin (Op De Beeck et al., 1995; Op De Beeck and
Caillet-Fauquet, 1997).
Infection of adeno-associated virus (AAV) leads to
accumulation of cells with 4N DNA content in p53-competent
cells, whereas it induces apoptosis in p53-deficient cells (Raj
et al., 2001). Interestingly, virus replication or viral protein
expression is not required for AAV-mediated cell cycle arrest
as ultraviolet-treated AAV maintain their ability to perturb cell
cycle, pointing to the role of AAV genome in these effects (Raj
et al., 2001). In support of this hypothesis, empty AAV particles,
which lack viral genome, fail to affect cell growth (Raj et al.,
2001). It was proposed that the special structure of AAV genome,
a single-stranded DNA with hairpin loops at both ends, could
trigger host DNA damage response and mediate cell cycle arrest
in a p53/p21WAF1/CIP1-dependent manner (Raj et al., 2001).
Indeed, using an oligonucleotide corresponding to the AAV
hairpin structure but not the AAV coding sequence, the same
group successfully replicated the phenotypes induced by AAV
infection (Raj et al., 2001). Likewise, expression of the individual
proteins of Bocavirus minute virus of canines (MVC) has no
effect on cell cycle progression (Chen et al., 2010). However,
TABLE 6 | Cell cycle subversion by other mechanisms.
Virus/Genome Viral protein Host protein Functional consequence References
Parvovirus minute virus of mice
/ssDNA
NS1 Chromatin Nicks affecting integrity, cell cycle arrest in S phase Op De Beeck et al., 1995; Op De
Beeck and Caillet-Fauquet, 1997
HIV-1/RNA plus Vpr Chromatin Activation of DNA damage response, G2 arrest Roshal et al., 2003; Lai et al., 2005
KSHV/dsDNA miRNA K1 p21WAF1/CIP1 Inhibition of p21WAF1/CIP1 expression, cell cycle
progression
Gottwein and Cullen, 2010
Adeno-associated virus/ssDNA Viral genome p53,
p21WAF1/CIP1
Activation of DNA damage response, cell cycle
arrest
Raj et al., 2001
Bocavirus minute virus of
canines/ssDNA
Viral genome G2/M arrest Sun et al., 2009; Chen et al., 2010
Measles virus/RNA minus Hemagglutinin, fusion
protein
Inhibition of T-cell expansion, accumulation in
G0/G1
Dubois et al., 2001; Griffin, 2010
Epstein-Barr/dsDNA miRNAs (BHRF1 locus) Inhibition of apoptosis and cell cycle progression Seto et al., 2010
Zika virus/RNA plus M, E, NS4A p53,
p21WAF1/CIP1
G2/M cell cycle arrest Li et al., 2017; Liu et al., 2018
Zika virus/RNA plus prM G1 accumulation Li et al., 2017
Avian Reovirus/dsRNA p17 Tpr nucleoporin Nuclear accumulation and activation of p53,
p21WAF1/CIP1 and PTEN, cell cycle arrest
Huang et al., 2015
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inoculation of UV-inactivated virus or a nonreplicative mutant
virus phenocopied the G2/M arrest induced by MVC infection,
suggesting that viral genome counts for the effect (Chen et al.,
2010). Indeed, the use of a series of MVC mutant constructs
indicated the terminal repeats of its genome, which form a strong
secondary structure, are essential in the G2/M arrest feature of
MVC (Sun et al., 2009; Chen et al., 2010).
Other than viral proteins and genome, virus-encoded
microRNAs (miRNAs) have been also implicated to play a role
in regulating host cell cycle. For example, KSHV miRNA K1
specifically represses the expression of p21WAF1/CIP1 via the
3′-UTR of this CKI, antagonizing p21WAF1/CIP1-mediated cell
cycle arrest (Gottwein and Cullen, 2010). The significance of
viral miRNA in favoring cell cycle progression was studied by
introducing mutations into the precursor miRNA transcripts
of EBV, which prevents the subsequent production of mature
viral miRNAs thus antagonizes both early B-cell proliferation
and miRNA protection from spontaneous apoptosis (Seto et al.,
2010).
Measles virus (MV) was reported to subvert dendritic cells
(DCs) and induce immune suppression. Dubois et al. found
that infection of DCs by MV led to their functional maturation,
allowing the migration of DCs frommucosal surfaces to draining
lymph nodes to prime naive T cells (Dubois et al., 2001).
Interestingly, instead of activating T cells, MV-infected DCs
block T-cell expansion through cell-to-cell contact. The use of
anti-MV HA or fusion protein (F) antibodies revealed that these
two viral proteins, which are expressed on virus-infected DCs,
are responsible for the suppression of T-cell proliferation (Dubois
et al., 2001). Thus, through surface expression of HA and F
on virus-infected DCs, MV takes a free ride on DCs to reach
draining lymph nodes and subverts the normal function of DCs
to inhibit T-cell proliferation. This infection-independent action
in T cells results in accumulation of cells in G0/G1, owing to
the inhibition of PI3K signaling in response to T-cell receptor
binding (Griffin, 2010).
Zika virus (ZIKV), a flavivirus that is transmitted to
humans primarily by Aedes mosquitoes, has been shown to
cause congenital microcephaly when it infects women early in
pregnancy (de Araújo et al., 2018; Hoen et al., 2018). This has
led to a flurry of studies in different experimental models that
have established the ZIKV induces massive abnormalities of cell
division, including the presence of supernumerary centrosomes,
that lead to virally-induced caspase 3-mediated apoptotic cell
death and cell cycle abnormalities of human neural progenitor
cells (Faizan et al., 2016; Souza et al., 2016; Gabriel et al., 2017),
although how it interferes with the cell cycle has not been
precisely defined. Moreover, transcriptional profiling of infected
human neural progenitor cells has revealed a dysregulation of cell
cycle- and differentiation-related pathways in neural progenitor
cells (Dang et al., 2016; Li et al., 2016; Tang et al., 2016).
Interestingly, it has been observed that an antiproliferactive
and pro-apoptotic p53-related response markedly different from
p53-induced transcriptional changes upon infection by HCMV,
which can also cause microcephaly, is activated in ZIKA-infected
human neural progenitor cells (Ghouzzi et al., 2016). More
recently, by investigating the effect of individual ZIKV proteins
in vitro, it was found that expression of the membrane-anchored
capsid anaC, structural envelope E, membrane M proteins, and
nonstructural protein 4A (NS4A) could trigger G2/M cell cycle
arrest and apoptosis (Li et al., 2017; Liu et al., 2018). The
NS4A induces growth restriction via the target of rapamycin
(TOR) cellular stress pathway (Li et al., 2017), whereas envelope-
triggered apoptosis is associated with upregulation of both p53
and p21Cip1/Waf1 and downregulation of cyclin B1 (Liu et al.,
2018). Interestingly, ZIKA membrane protein (M) induce arrest
of the cell cycle in G2/M, whereas the pre-membrane protein
(prM) results in G1 accumulation (Li et al., 2017), revealing that
posttranslational processing modifies its interference with cell
cycle progression.
CONCLUSIONS
The interplay between the life cycle of viruses and the series
of events leading to cell division has been actively investigated
since the discovery that certain tumors were associated to
viral infection. Although estimates of the incidence of cancers
caused by viruses vary, both DNA and RNA viruses have
been clearly linked to the development of human cancers
(Liao, 2006; Mesri et al., 2014). However, most viruses have
evolved a more complicated relationship with the cell cycle
contenting themselves with surreptitious tampering for more
effective replication and productive infection, without leading
to cell transformation and tumorigenesis. The most obvious
mechanism is the direct interaction of a viral gene product
with a host protein to disarm its function, which has been
adopted by many viruses as a common strategy to exploit
host cell cycle. It is commonly held that, by interacting with
cell cycle regulators and delaying cell division, these viruses
can subvert the biosynthetic apparatus, re-directing it from the
production of host proteins needed for cell cycle progression
to suit their replication needs. Viruses stop at nothing and use
any means necessary to survive in a hostile environment by
inducing posttranslational modifications and dislocating host
restriction factors to modulate their function and/or degradation.
Co-evolution and adaptation of virus-host interactions is best
described as a zero-sum biological arms race. It is clear that
viruses could utilize different nodes of the cell cycle machinery
to hamper cell division to escape the dependency on the normal
progression of cellular proliferation. The mechanistic study of
these interactions has revealed unexpected, non-canonical roles
of cellular proteins. Further work should bring about a more
refined understanding that will shed new light on the panoply of
assets available to viruses to subvert the process of cell division,
while at the same time providing insight into the function of host
proteins that can offer unexpected handles to counteract viral
infection.
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